126 related articles for article (PubMed ID: 29858097)
1. Association between perioperative beta blocker use and cancer survival following surgical resection.
Musselman RP; Bennett S; Li W; Mamdani M; Gomes T; van Walraven C; Boushey R; Al-Obeed O; Al-Omran M; Auer RC
Eur J Surg Oncol; 2018 Aug; 44(8):1164-1169. PubMed ID: 29858097
[TBL] [Abstract][Full Text] [Related]
2. β-Blockade in Rectal Cancer Surgery: A Simple Measure of Improving Outcomes.
Ahl R; Matthiessen P; Fang X; Cao Y; Sjolin G; Lindgren R; Ljungqvist O; Mohseni S
Ann Surg; 2020 Jan; 271(1):140-146. PubMed ID: 30048321
[TBL] [Abstract][Full Text] [Related]
3. Preoperative β-blocker use in coronary artery bypass grafting surgery: national database analysis.
Brinkman W; Herbert MA; O'Brien S; Filardo G; Prince S; Dewey T; Magee M; Ryan W; Mack M
JAMA Intern Med; 2014 Aug; 174(8):1320-7. PubMed ID: 24934977
[TBL] [Abstract][Full Text] [Related]
4. Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study.
Weberpals J; Jansen L; Haefeli WE; Hoffmeister M; Wolkewitz M; Herk-Sukel MPPV; Vissers PAJ; Brenner H
Sci Rep; 2017 Jun; 7(1):2911. PubMed ID: 28588274
[TBL] [Abstract][Full Text] [Related]
5. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
[TBL] [Abstract][Full Text] [Related]
6. Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.
Jansen L; Weberpals J; Kuiper JG; Vissers PAJ; Wolkewitz M; Hoffmeister M; Brenner H
Int J Cancer; 2017 Jul; 141(1):62-71. PubMed ID: 28370155
[TBL] [Abstract][Full Text] [Related]
7. Effects of beta-blocker therapy on mortality after elective colon cancer surgery: a Swedish nationwide cohort study.
Ahl R; Matthiessen P; Sjölin G; Cao Y; Wallin G; Ljungqvist O; Mohseni S
BMJ Open; 2020 Jul; 10(7):e036164. PubMed ID: 32641361
[TBL] [Abstract][Full Text] [Related]
8. β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.
Livingstone E; Hollestein LM; van Herk-Sukel MP; van de Poll-Franse L; Nijsten T; Schadendorf D; de Vries E
Eur J Cancer; 2013 Dec; 49(18):3863-71. PubMed ID: 23942335
[TBL] [Abstract][Full Text] [Related]
9. β-Blocker-Associated Risks in Patients With Uncomplicated Hypertension Undergoing Noncardiac Surgery.
Jørgensen ME; Hlatky MA; Køber L; Sanders RD; Torp-Pedersen C; Gislason GH; Jensen PF; Andersson C
JAMA Intern Med; 2015 Dec; 175(12):1923-31. PubMed ID: 26436291
[TBL] [Abstract][Full Text] [Related]
10. Management and Outcome of Colorectal Cancer Liver Metastases in Elderly Patients: A Population-Based Study.
Booth CM; Nanji S; Wei X; Mackillop WJ
JAMA Oncol; 2015 Nov; 1(8):1111-9. PubMed ID: 26355283
[TBL] [Abstract][Full Text] [Related]
11. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
Weberpals J; Jansen L; van Herk-Sukel MPP; Kuiper JG; Aarts MJ; Vissers PAJ; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):1019-1031. PubMed ID: 28864947
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of β-blocker use in pulmonary arterial hypertension: a propensity-matched analysis.
Bandyopadhyay D; Bajaj NS; Zein J; Minai OA; Dweik RA
Eur Respir J; 2015 Sep; 46(3):750-60. PubMed ID: 26022959
[TBL] [Abstract][Full Text] [Related]
13. Stage-specific associations between beta blocker use and prognosis after colorectal cancer.
Jansen L; Hoffmeister M; Arndt V; Chang-Claude J; Brenner H
Cancer; 2014 Apr; 120(8):1178-86. PubMed ID: 24415516
[TBL] [Abstract][Full Text] [Related]
14. β-Blockers in Atrial Fibrillation Patients With or Without Heart Failure: Association With Mortality in a Nationwide Cohort Study.
Nielsen PB; Larsen TB; Gorst-Rasmussen A; Skjøth F; Lip GY
Circ Heart Fail; 2016 Feb; 9(2):e002597. PubMed ID: 26823497
[TBL] [Abstract][Full Text] [Related]
15. Preoperative beta-blocker usage: is it really worthy of being a quality indicator?
Brinkman WT; Herbert MA; Prince SL; Magee MJ; Dewey TM; Smith RL; Edgerton JR; Head SJ; Ryan WH; Mack MJ
Ann Thorac Surg; 2011 Sep; 92(3):788-95; discussion 795-6. PubMed ID: 21704300
[TBL] [Abstract][Full Text] [Related]
16. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
[TBL] [Abstract][Full Text] [Related]
17. Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA; Håheim LL
Prostate; 2013 Feb; 73(3):250-60. PubMed ID: 22821802
[TBL] [Abstract][Full Text] [Related]
18. Association of perioperative β-blockade with mortality and cardiovascular morbidity following major noncardiac surgery.
London MJ; Hur K; Schwartz GG; Henderson WG
JAMA; 2013 Apr; 309(16):1704-13. PubMed ID: 23613075
[TBL] [Abstract][Full Text] [Related]
19. Effect of beta-blocker therapy on early mortality after emergency colonic cancer surgery.
Ahl R; Matthiessen P; Fang X; Cao Y; Sjolin G; Lindgren R; Ljungqvist O; Mohseni S
Br J Surg; 2019 Mar; 106(4):477-483. PubMed ID: 30259967
[TBL] [Abstract][Full Text] [Related]
20. 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study.
van Maaren MC; de Munck L; de Bock GH; Jobsen JJ; van Dalen T; Linn SC; Poortmans P; Strobbe LJA; Siesling S
Lancet Oncol; 2016 Aug; 17(8):1158-1170. PubMed ID: 27344114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
